FutureCare Studies

Springfield, Massachusetts 72205

0 studies enrolling now · 21 studies all time

What they study most

Alzheimer Disease, Arthritis, Rheumatoid, Back Pain Lower Back Chronic, Chronic Pain, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2, Fibromyalgia, Genital Herpes, Gout, Hepatitis C, Chronic, Major Depressive Disorder, Nocturia

Studies at this site

• Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs — Completed
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Investigation of the Superiority Effect of Desmopressin to Placebo in Terms of Night Voids Reduction in Nocturia Adult Female Patients — Completed
• A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes — Completed
• A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects — Completed
• Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes — Completed
• A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) — Completed
• An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type — Completed
• A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee — Completed
• Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity — Completed
• MPC-004 for the Treatment of an Acute Gout Flare — Completed
• Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 — Stopped early
• Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension. — Stopped early
• Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain — Stopped early
• Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. — Completed
• A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia — Completed
• Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes — Completed
• Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee — Completed
• Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder — Stopped early
• Long-Term Follow-Up Study of Psoriasis Patients — Completed
• A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis — Completed